Results 71 to 80 of about 29,439 (214)

Modular Nanosensing Platforms for Tuberculosis and Beyond: Engineering Biomaterials Toward Cross‐Pathogen Diagnostic Universality

open access: yesMedComm – Biomaterials and Applications, Volume 4, Issue 4, December 2025.
Modular nanosensing platforms utilize nanomaterials and functionalized interfaces to amplify trace different pathogens (like tuberculosis) antigen capture, suppress matrix interference, and enable multiplex detection. Their portability and cost‐effectiveness support rapid screening in resource‐limited settings and real‐time monitoring, advancing high ...
Mei Li   +6 more
wiley   +1 more source

Next‐Generation Sequencing in Infectious‐Disease Diagnostics: Economic, Regulatory, and Clinical Pathways to Adoption

open access: yesMicrobiologyOpen, Volume 14, Issue 6, December 2025.
Next‐generation sequencing (NGS) is poised to transform infectious‐disease diagnostics. Falling per‐sample costs, new CPT codes and FDA pathways, and 24‐h, multiplexed resistome reports converge to deliver faster, evidence‐based therapy and stronger surveillance. Our roadmap links the economic, regulatory, and clinical pillars to accelerate routine NGS
John Osei Sekyere
wiley   +1 more source

Carbapenemase-producingAcinetobacterspp. in Cattle, France

open access: yesEmerging Infectious Diseases, 2012
To the Editor: Multidrug resistance in bacteria isolated from animals is an emerging phenomenon, mirroring what is happening among humans. During the past decade, expanded-spectrum β-lactamases in Enterobacteriaceae from humans (1) and animals (2) worldwide have been reported.
Poirel, Laurent   +5 more
openaire   +3 more sources

Phenotype Characterization of Beta-Lactamase Producing Enterobacteriaceae in the Intensive Care Unit (ICU) of Cipto Mangunkusumo Hospital in 2011

open access: yesActa Medica Indonesiana, 2016
Aim: the goal of this study is to understand the phenotype characteristic of beta-lactamase enzymes producing Enterobacteriaceae, such as ESBL, AmpC, and carbapenemase.
Yulia R Saharman, Delly C Lestari
doaj   +2 more sources

Intrapatient transfer of an uncommon carbapenemase in Nebraska [PDF]

open access: bronze, 2021
Alyssa K. W. Maclean   +5 more
openalex   +1 more source

Evaluation of the CARBA PAcE test, a colorimetric imipenem hydrolysis test for rapid detection of carbapenemase activity

open access: yesMicrobiology Spectrum
There is an urgent need for accurate and fast diagnostic tests to identify carbapenemase-producing bacteria. Here, we evaluated a colorimetric imipenem hydrolysis test, called the CARBA PAcE test, to detect carbapenemase-producing Gram-negative bacteria (
Nadya Rakovitsky   +8 more
doaj   +1 more source

Molecular epidemiology of carbapenemases in Enterobacterales in tertiary care hospital and comparison of three phenotypic carbapenemase detection methods

open access: yesJournal of Global Antimicrobial Resistance
AIM: This study aims to investigate current molecular epidemiology of carbapenemases in Enterobacterales in tertiary care hospital and comparison of phenotypic carbapenemase detection methods. Molecular tests were used as the gold standard.
Mustafa Yılmaz, Gül Durmaz
doaj   +1 more source

Functional categorization of carbapenemase-mediated resistance by a combined genotyping and two-tiered Modified Hodge Test approach

open access: yesFrontiers in Microbiology, 2015
The functional relationship between carbapenemase production and phenotypic resistance in Gram negative bacterial pathogens is often ill-defined. To address this issue, we developed a two-tiered Modified Hodge Test (MHT) approach for carbapenemase ...
Marcus Ho-yin Wong   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy